Martinez, Jerry A.
HRN: 25-74-86 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/26/2024
CO-AMOXICLAV 625MG (TAB)
08/26/2024
09/02/2024
PO
625 Mg Tab
TID
MVA
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes